Search Tag: Immuno-Oncology

Executive Health Management

HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

2022 07 Jul

 Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX’s Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of breakthrough cancer immunotherapy checkpoint inhibitors, Yervoy... Read more

Executive Health Management

15th Annual Biomarker World Congress 2019

2019 17 Jun

Find Cambridge Healthtech Institute on Social Media Read more